Recently, intrathecal single-dose ISIS333611 infusion was administered to four cohorts of eight patients with SOD1-related ALS: in each cohort, six patients received ISIS333611 and two patients received a placebo [16]. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.